Insufficient scRNA-seq data for expression of SSTR5 at single-cell level.
Insufficient scRNA-seq data for expression of SSTR5 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 77% | 47.73 | 189 / 245 | 47% | 1.31 | 236 / 502 |
adrenal gland | 93% | 159.91 | 241 / 258 | 28% | 7.96 | 65 / 230 |
kidney | 75% | 75.47 | 67 / 89 | 27% | 1.52 | 241 / 901 |
ureter | 0% | 0 | 0 / 0 | 100% | 8.26 | 1 / 1 |
heart | 92% | 286.58 | 789 / 861 | 0% | 0 | 0 / 0 |
pancreas | 43% | 11.30 | 140 / 328 | 42% | 1.65 | 74 / 178 |
blood vessel | 64% | 70.42 | 849 / 1335 | 0% | 0 | 0 / 0 |
intestine | 4% | 0.76 | 41 / 966 | 48% | 3.87 | 253 / 527 |
stomach | 8% | 1.40 | 27 / 359 | 44% | 3.31 | 125 / 286 |
bladder | 29% | 12.76 | 6 / 21 | 22% | 1.35 | 112 / 504 |
esophagus | 6% | 2.38 | 84 / 1445 | 42% | 2.33 | 76 / 183 |
brain | 11% | 3.75 | 299 / 2642 | 31% | 0.69 | 219 / 705 |
tonsil | 0% | 0 | 0 / 0 | 36% | 1.76 | 16 / 45 |
uterus | 3% | 0.55 | 5 / 170 | 27% | 2.05 | 122 / 459 |
liver | 0% | 0.14 | 1 / 226 | 26% | 2.66 | 104 / 406 |
muscle | 21% | 7.64 | 168 / 803 | 0% | 0 | 0 / 0 |
lung | 1% | 0.87 | 5 / 578 | 16% | 0.71 | 185 / 1155 |
adipose | 11% | 2.09 | 128 / 1204 | 0% | 0 | 0 / 0 |
skin | 7% | 1.52 | 131 / 1809 | 1% | 0.03 | 4 / 472 |
breast | 3% | 0.52 | 15 / 459 | 5% | 0.24 | 53 / 1118 |
thymus | 1% | 0.27 | 7 / 653 | 3% | 0.13 | 16 / 605 |
ovary | 1% | 0.22 | 2 / 180 | 2% | 0.04 | 7 / 430 |
eye | 0% | 0 | 0 / 0 | 1% | 0.04 | 1 / 80 |
peripheral blood | 1% | 0.46 | 10 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
GO_0071385 | Biological process | cellular response to glucocorticoid stimulus |
GO_0008285 | Biological process | negative regulation of cell population proliferation |
GO_0038170 | Biological process | somatostatin signaling pathway |
GO_0007186 | Biological process | G protein-coupled receptor signaling pathway |
GO_0007218 | Biological process | neuropeptide signaling pathway |
GO_0050796 | Biological process | regulation of insulin secretion |
GO_0032467 | Biological process | positive regulation of cytokinesis |
GO_0007187 | Biological process | G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger |
GO_0005886 | Cellular component | plasma membrane |
GO_0043005 | Cellular component | neuron projection |
GO_0042923 | Molecular function | neuropeptide binding |
GO_0004994 | Molecular function | somatostatin receptor activity |
GO_0005515 | Molecular function | protein binding |
Gene name | SSTR5 |
Protein name | Somatostatin receptor subtype 5B Somatostatin receptor type 5 (SS-5-R) (SS5-R) (SS5R) (SST5) Somatostatin receptor subtype 5C |
Synonyms | |
Description | FUNCTION: Receptor for somatostatin 28 and to a lesser extent for somatostatin-14. The activity of this receptor is mediated by G proteins which inhibit adenylyl cyclase. Increases cell growth inhibition activity of SSTR2 following heterodimerization. . |
Accessions | ENST00000689027.1 D2CFK4 D2CFK5 P35346 ENST00000293897.6 |